23 results
8-K
EX-14.1
DAWN
Day One Biopharmaceuticals, Inc.
8 Dec 23
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:05pm
bribery or corruption in any form or for any purpose. There is no potential benefit that can justify damaging our integrity and reputation or the trust
424B5
vmf852anzf fo
16 Jun 22
Prospectus supplement for primary offering
7:30am
424B5
wmsxl
14 Jun 22
Prospectus supplement for primary offering
7:39am
10-K
EX-10.2
bpufx211azxkziu6hso
7 Mar 22
Annual report
7:36am
10-K
iypqr03mu8ct4
7 Mar 22
Annual report
7:36am
10-Q
yyvg5q7
10 Aug 21
Quarterly report
5:26pm
424B4
ibbsu99fuaklotzg3ebe
27 May 21
Prospectus supplement with pricing info
4:18pm
S-1/A
EX-10.9
6d9kc
24 May 21
IPO registration (amended)
6:16am